Original Communication| Volume 147, ISSUE 3, P358-365, March 2010

Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival

Published:December 04, 2009DOI:


      Survival in colon cancer is greater in those patients who have more lymph nodes identified at resection and may be due to stage migration, confounding by treatment, social, or clinical characteristics. Identifying factor(s) responsible for the effect may represent an opportunity to improve quality of care for patients with colon cancer by increasing node counts in specimens.


      Cox proportional hazards models were created to analyze survival of 11,399 patients with stage I-III colon cancer from the Surveillance, Epidemiology and End Results (SEER)-Medicare database. The primary predictor variable was the number of lymph nodes identified. The models allowed adjustment for patient factors, use of chemotherapy, surgical specialty, and the average number of nodes identified by surgeon and hospital pathologist.


      The number of nodes identified was related to survival. Compared to those with less than 7 nodes, patients with 7 to 11 nodes had a 13% lesser risk of death (hazard ratio [HR], 0.87; 95% confidence interval [CI], 0.76–0.99; P = .037). Patients with more than 12 nodes had a 17% lesser risk (HR, 0.83; 95% CI, 0.73–0.95; P = .005). Adjusting for selected patient demographic characteristics, receipt of chemotherapy, surgical specialty, and the average number of nodes identified per specimen by the surgeon or hospital did not significantly alter the relationship between number of nodes and survival.


      These findings argue against understaging or confounding as the explanation for the inferior survival observed in patients with fewer nodes identified. National initiatives to increase the number of nodes identified in colon cancer specimens may not improve substantially the cancer-specific outcomes.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Chen S.L.
        • Bilchik A.J.
        More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study.
        Ann Surg. 2006; 244: 602-610
        • Le Voyer T.E.
        • Sigurdson E.R.
        • Hanlon A.L.
        • et al.
        Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.
        J Clin Oncol. 2003; 21: 2912-2919
        • Johnson P.M.
        • Porter G.A.
        • Ricciardi R.
        • Baxter N.N.
        Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer.
        J Clin Oncol. 2006; 24: 3570-3575
        • Nelson H.
        • Petrelli N.
        • Carlin A.
        • et al.
        Guidelines 2000 for colon and rectal cancer surgery.
        J Natl Cancer Inst. 2001; 93: 583-596
        • Fielding L.P.
        • Arsenault P.A.
        • Chapuis P.H.
        • et al.
        Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT).
        J Gastroenterol Hepatol. 1991; 6: 325-344
        • Otchy D.
        • Hyman N.H.
        • Simmang C.
        • et al.
        Practice parameters for colon cancer.
        Dis Colon Rectum. 2004; 47: 1269-1284
        • Chang G.J.
        • Rodriguez-Bigas M.A.
        • Skibber J.M.
        • Moyer V.A.
        Lymph node evaluation and survival after curative resection of colon cancer: systematic review.
        J Natl Cancer Inst. 2007; 99: 433-441
        • Pihl E.
        • Nairn R.C.
        • Nind A.P.
        • et al.
        Correlation of regional lymph node in vitro antitumor immunoreactivity histology with colorectal carcinoma.
        Cancer Res. 1976; 36: 3665-3671
        • Fisher E.R.
        • Saffer E.
        • Fisher B.
        Studies concerning the regional lymph node in cancer. VI. Correlation of lymphocyte transformation of regional node cells and some histopathologic discriminants.
        Cancer. 1973; 32: 104-111
        • Patt D.J.
        • Brynes R.K.
        • Vardiman J.W.
        • Coppleson L.W.
        Mesocolic lymph node histology is an important prognostic indicator for patients with carcinoma of the sigmoid colon: an immunomorphologic study.
        Cancer. 1975; 35: 1388-1396
        • Murray D.
        • Hreno A.
        • Dutton J.
        • Hampson L.G.
        Prognosis in colon cancer: a pathologic reassessment.
        Arch Surg. 1975; 110: 908-913
        • Wong S.L.
        • Ji H.
        • Hollenbeck B.K.
        • et al.
        Hospital lymph node examination rates and survival after resection for colon cancer.
        JAMA. 2007; 298: 2149-2154
      1. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) program. Available at Accessed on May 31, 2007.

      2. National Cancer Institute. Surveillance, Epidemiology, and End Results. Available at: Accessed on May 31, 2007.

        • Schrag D.
        • Cramer L.D.
        • Bach P.B.
        • et al.
        Influence of hospital procedure volume on outcomes following surgery for colon cancer.
        JAMA. 2000; 284: 3028-3035
        • Caplin S.
        • Cerottini J.P.
        • Bosman F.T.
        • et al.
        For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
        Cancer. 1998; 83: 666-672
        • Wears R.L.
        Advanced statistics: statistical methods for analyzing cluster and cluster-randomized data.
        Acad Emerg Med. 2002; 9: 330-341
        • Swanson R.S.
        • Compton C.C.
        • Stewart A.K.
        • Bland K.I.
        The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined.
        Ann Surg Oncol. 2003; 10: 65-71
        • Prandi M.
        • Lionetto R.
        • Bini A.
        • et al.
        Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial.
        Ann Surg. 2002; 235: 458-463
        • Bui L.
        • Rempel E.
        • Reeson D.
        • Simunovic M.
        Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study.
        J Surg Oncol. 2006; 93: 439-445
        • Pihl E.
        • Nairn R.C.
        • Milne B.J.
        • et al.
        Lymphoid hyperplasia: a major prognostic feature in 519 cases of colorectal carcinoma.
        Am J Pathol. 1980; 100: 469-480
        • Nacopoulou L.
        • Azaris P.
        • Papacharalampous N.
        • Davaris P.
        Prognostic significance of histologic host response in cancer of the large bowel.
        Cancer. 1981; 47: 930-936
        • Halvorsen T.B.
        • Seim E.
        Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer.
        J Clin Pathol. 1989; 42: 162-166
        • Pages F.
        • Berger A.
        • Camus M.
        • et al.
        Effector memory T cells, early metastasis, and survival in colorectal cancer.
        N Engl J Med. 2005; 353: 2654-2666
        • Galon J.
        • Costes A.
        • Sanchez-Cabo F.
        • et al.
        Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
        Science. 2006; 313: 1960-1964
        • Gilligan M.A.
        • Neuner J.
        • Zhang X.
        • et al.
        Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer.
        Am J Public Health. 2007; 97: 539-544
        • Schrag D.
        • Earle C.
        • Xu F.
        • et al.
        Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.
        J Natl Cancer Inst. 2006; 98: 163-171
        • Schrag D.
        • Panageas K.S.
        • Riedel E.
        • et al.
        Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection.
        J Surg Oncol. 2003; 83 (discussion, 78-9): 68-78